Novantrone for MS 5-year phase IV RENEW study results report

A board to discuss the Multiple Sclerosis modifying drug Novantrone

Novantrone for MS 5-year phase IV RENEW study results report

Postby MSUK » Thu Jul 11, 2013 3:03 am

Novantrone for MS 5-year phase IV RENEW study results reported

Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis (RENEW) was a 5-year, phase IV study in which the safety of Mitoxantrone was monitored in a patient cohort from the United States (US). The objective of the study was to evaluate the long-term safety profile of Mitoxantrone in patients with secondary progressive multiple sclerosis (SPMS), progressive relapsing multiple sclerosis (PRMS), and worsening relapsing-remitting multiple sclerosis (RRMS)..... Read More - http://www.ms-uk.org/index.cfm/novantrone
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2123
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Novantrone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron